Pinter, Matthias http://orcid.org/0000-0002-7260-532X
Sieghart, Wolfgang
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 9 June 2018
Accepted: 7 August 2018
First Online: 24 August 2018
Conflict of interest
: M. Pinter is advisory board member of Bayer, BMS, Eisai, and Ipsen, and received travel support from Bayer, and speaking fees from Bayer and BMS. He is also an investigator for Bayer, BMS, and Lilly. W. Sieghart received speaker and consulting fees and research grants from Bayer Schering Pharma.